On Monday, biopharmaceutical company Amgen
- Revenues just barely missed the analyst consensus, while EPS fell short by $0.04.
- Revenues increased 14.5%, driven by a 14% increase in U.S. product sales and an 18% increase in international sales.
- Amgen's EPS climbed 22.1% because of an increase in net profit and a 5.7% decrease in diluted share count.
- Long-term debt increased 229% because $2.5 billion of convertible notes due in 2011 and $2.5 billion of convertible notes due in 2013 were issued.
(Figures in millions, except per-share data)
Income Statement Highlights
|
Avg. Est. |
Q3 2006 |
Q3 2005 |
Change |
|
|---|---|---|---|---|
|
Sales |
$3,616 |
$3,612 |
$3,154 |
14.5% |
|
Net Profit |
-- |
$1,102 |
$967 |
14.0% |
|
EPS |
$0.98 |
$0.94 |
$0.77 |
22.1% |
|
Diluted Shares |
-- |
1,178 |
1,249 |
(5.7%) |
Get back to basics with a look at the income statement.
Margin Checkup
|
Q3 2006 |
Q3 2005 |
Change* |
|
|---|---|---|---|
|
Gross Margin |
86.46% |
82.50% |
3.96 |
|
Operating Margin |
36.60% |
41.15% |
(4.55) |
|
Net Margin |
30.51% |
30.66% |
(0.15) |
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
Assets | Q3 2006 | Q3 2005 | Change |
|---|---|---|---|
Cash + ST Invest. | $5,781 | $5,551 | 4.1% |
Accounts Rec. | $2,124 | $1,664 | 27.6% |
Inventory | $1,711 | $1,059 | 61.6% |
Liabilities | Q3 2006 | Q3 2005 | Change |
|---|---|---|---|
Accounts Payable* | $4,515 | $3,352 | 34.7% |
Long-Term Debt | $9,006 | $4,070 | 121.3% |
Learn the ways of the balance sheet.
Cash Flow Highlights
Q3 2006 | Q3 2005 | Change | |
|---|---|---|---|
Cash From Ops. | N/A | $1,442 | N/A |
Capital Expenditures | $376 | $199 | 88.9% |
Free Cash Flow | N/A | $1,243 | N/A |
Find out why Fools always follow the money.
Related companies:
- Biogen Idec
(NASDAQ:BIIB) - Genentech
(NYSE:DNA) - Genzyme
(NASDAQ:GENZ)
Related Foolishness:
- Amgen's Ho-Hum Quarter
- Amgen Secures Its Future
- Amgen's Little Helpers
- DNA Sequencing Sprouts Small Roots
Biogen Idec is aMotley Fool Stock Advisorselection. What other stocks are at the top of Tom and David Gardner's list? Be our guest at the Stock Advisor website for 30 days and find out.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so checkFool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.
